Seneca Biopharma Reports 2020 First Quarter Results
GERMANTOWN, Md., May 15, 2020 /PRNewswire/ — Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today reported its financial results for the quarter ended March 31, 2020. Business Highlights…
Comments Off on Seneca Biopharma Reports 2020 First Quarter Results